当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:27.07亿  总市值:30.95亿
流通股本:3.67亿   总股本:4.20亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.19亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益238401.42万元,未分配利润64323.02万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产331162.09万元,负债92760.68万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入184,392,671.37828,659,350.98636,241,288.48427,422,152.61
营业总成本167,876,632.18702,520,673.31520,768,052.25341,667,938.34
其他经营收益
营业利润19,615,993.974,894,385.2291,735,058.464,581,581.97
利润总额19,615,993.975,576,727.4492,417,400.6264,581,632.99
净利润18,779,502.7173,091,433.3183,664,591.0458,486,512.57
每股收益
其他综合收益----
综合收益总额18,779,502.7173,091,433.3183,664,591.0458,486,512.57
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,433,803,022.481,461,727,700.921,490,389,022.331,239,075,084.93
非流动资产:
非流动资产合计1,877,817,922.381,859,305,914.441,767,962,182.252,029,409,249.59
资产总计3,311,620,944.863,321,033,615.363,258,351,204.583,268,484,334.52
流动负债:
流动负债合计787,920,144.82666,921,271.86582,555,347.13411,224,471.07
非流动负债:
非流动负债合计139,686,649.74288,877,695.91299,988,052.13506,630,136.6
负债合计927,606,794.56955,798,967.77882,543,399.26917,854,607.67
所有者权益(或股东权益):
归属于母公司股东权益合计2,384,014,150.32,365,234,647.592,375,807,805.322,350,629,726.85
股东权益合计2,384,014,150.32,365,234,647.592,375,807,805.322,350,629,726.85
负债和股东权益合计3,311,620,944.863,321,033,615.363,258,351,204.583,268,484,334.52
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计194,284,667.55830,137,521.27607,846,011.87420,756,510.11
经营活动现金流出小计171,822,012.65628,066,783.76414,664,396.73292,940,802.88
经营活动产生的现金流量净额22,462,654.9202,070,737.51193,181,615.14127,815,707.23
投资活动产生的现金流量:
投资活动现金流入小计164,277,519.35600,038,022.72467,217,368.12366,493,335.32
投资活动现金流出小计298,197,822.39616,946,774.65435,575,994.9196,032,228.44
投资活动产生的现金流量净额-133,920,303.04-16,908,751.9331,641,373.22170,461,106.88
筹资活动产生的现金流量:
筹资活动现金流入小计59,712,000469,890,512.13358,014,762.13232,580,000
筹资活动现金流出小计86,664,175.71567,855,028.09507,117,084.41338,975,044.79
筹资活动产生的现金流量净额-26,952,175.71-97,964,515.96-149,102,322.28-106,395,044.79
汇率变动对现金及现金等价物的影响-4,187,012.02233,576.11,405,439.241,613,697.98
现金及现金等价物净增加额-142,596,835.8787,431,045.7277,126,105.32193,495,467.3
期末现金及现金等价物余额110,246,447.61252,843,283.48242,538,343.08358,907,705.06
补充资料:
现金及现金等价物的净增加额-87,431,045.72-193,495,467.3
最新报告期:2026-05-02
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
招商证券侯彪,梁广楷,许菲菲0.200.240.302026-05-02
TOP↑